Researchers are developing an implantable device that could prevent pregnancy and HIV for two years
A) Scanning electron microscopy of implant nanoscale channels controlling drug release, B) Design [...]
UW Bioengineers pivot to develop coronavirus solutions
A number of UW Bioengineering faculty members quickly pivoted and are adapting their research to addressing the needs created by the coronavirus pandemic. From developing rapid at-home tests and protective masks to vaccines and treatments, here is a sampling of some of the ways UW BioE faculty, staff and students are stepping up to help.
Online Master of Pharmaceutical Bioengineering prepares working professionals to drive drug discovery, development
In this professional master's degree program, students gain cutting-edge knowledge in basic bioscience, drug discovery and pharmaceutics, and learn how to apply their expertise to market-based demands of pharmaceutical industry.
UW, Academia Sinica researchers develop “drug capture system” to treat limb ischemia
UW Bioengineering faculty James Lai, Suzie Pun and Patrick Stayton, and BioE Ph.D. alumnus and affiliate faculty member Patrick Hsieh, are among contributing authors of a paper describing a novel treatment for limb ischemia.
Patrick Stayton, Valerie Daggett to present 2016-17 Science in Medicine Lectures
Patrick Stayton, the Distinguished Career Professor of Bioengineering and director of the UW Molecular Engineering and Sciences Institute, and Valerie Daggett, professor of bioengineering, will present 2016-2017 UW Medicine Science in Medicine Lectures.
Patrick Stayton named Distinguished Career Professor of Bioengineering
Boldly pursuing the forefront of molecular engineering and nanotechnology, Patrick Stayton embodies UW Bioengineering’s mission to invent the future of medicine.
Coulter program helps launch BioE technologies toward clinical impact
Medical test and drug development technologies from UW Bioengineering have spun out into start-ups Nexgenia and Nanosurface Biomedical, with Coulter's help.
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine
“Big Potential in Going Small”: Patrick Stayton’s nanotechnology research mentioned in Alaska Airlines Magazine. The article explores the history of nanotechnology, its current application and Dr. Stayton’s current work developing a nanotechnology delivery system to treat certain diseases, including liver cancer.
Computer-designed protein causes cancer cells to self-destruct
UW researchers, including BioE Professor Patrick Stayton and many collaborators from the UW and Fred Hutchinson Cancer Research Center, have created a protein molecule that can prompt cancer cells infected with the Epstein-Barr virus to self-destruct.
UW Bioengineering welcomes BMES to Seattle, Hosts Lab Tours
Seattle hosted the 2013 BMES Annual Meeting, and UW Bioengineering student, faculty and staff volunteers were present in force to welcome, engage and educate over 4,000 conference attendees.
Castner, Stayton, Yager join WA State Academy of Sciences
UW Bioengineering professors David Castner, Paul Yager and Patrick Stayton named to Washington State Academy of Sciences.